{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T23:08:04Z","timestamp":1772060884356,"version":"3.50.1"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Hyperbaric oxygen therapy (HBOT) has several hemodynamic effects including increases in afterload (due to vasoconstriction) and decreases in cardiac output. This, along with rare reports of pulmonary edema during emergency treatment, has led providers to consider HBOT relatively contraindicated in patients with reduced left ventricular ejection fraction (LVEF). However, there is limited evidence regarding the safety of elective HBOT in patients with heart failure (HF), and no existing reports of complications among patients with HF and preserved LVEF. We aimed to retrospectively review patients with preexisting diagnoses of HF who underwent elective HBOT, to analyze HBOT-related acute HF complications.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Research Ethics Board approvals were received to retrospectively review patient charts. Patients with a history of HF with either preserved ejection fraction (HFpEF), mid-range ejection fraction (HFmEF), or reduced ejection fraction (HFrEF) who underwent elective HBOT at two Hyperbaric Centers (Toronto General Hospital, Rouge Valley Hyperbaric Medical Centre) between June 2018 and December 2020 were reviewed.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Twenty-three patients with a history of HF underwent HBOT, completing an average of 39 (range 6\u201362) consecutive sessions at 2.0 atmospheres absolute (ATA) (n = 11) or at 2.4 ATA (n = 12); only two patients received fewer than 10 sessions. Thirteen patients had HFpEF (mean LVEF 55 \u00b1 7%), and seven patients had HFrEF (mean LVEF 35 \u00b1 8%) as well as concomitantly decreased right ventricle function (n = 5), moderate\/severe tricuspid regurgitation (n = 3), or pulmonary hypertension (n = 5). The remaining three patients had HFmEF (mean LVEF 44 \u00b1 4%). All but one patient was receiving fluid balance therapy either with loop diuretics or dialysis.<\/jats:p>\n<jats:p>Twenty-one patients completed HBOT without complications. We observed symptoms consistent with HBOT-related HF exacerbation in two patients. One patient with HFrEF (LVEF 24%) developed dyspnea attributed to pulmonary edema after the fourth treatment, and later admitted to voluntarily holding his diuretics before the session. He was managed with increased oral diuretics as an outpatient, and ultimately completed a course of 33 HBOT sessions uneventfully. Another patient with HFpEF (LVEF 64%) developed dyspnea and desaturation after six sessions, requiring hospital admission. Acute coronary ischemia and pulmonary embolism were ruled out, and an elevated BNP and normal LVEF on echocardiogram confirmed a diagnosis of pulmonary edema in the context of HFpEF. Symptoms subsided after diuretic treatment and the patient was discharged home in stable condition, but elected not to resume HBOT.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Patients with HF, including HFpEF, may develop HF symptoms during HBOT and warrant ongoing surveillance. However, these patients can receive HBOT safely after optimization of HF therapy and fluid restriction.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0293484","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T18:49:26Z","timestamp":1707418166000},"page":"e0293484","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Safety of hyperbaric oxygen therapy in patients with heart failure: A retrospective cohort study"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3609-9201","authenticated-orcid":true,"given":"Simone","family":"Schiavo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6126-3897","authenticated-orcid":true,"given":"Connor T. A.","family":"Brenna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Albertini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Djaiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Marinov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Katznelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,2,8]]},"reference":[{"key":"pone.0293484.ref001","volume-title":"Hyperbaric Oxygen Therapy Indications","author":"E. Huang","year":"2023","edition":"15"},{"key":"pone.0293484.ref002","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-3-319-47140-2_8","volume-title":"Textbook of Hyperbaric Medicine","author":"KK Jain","year":"2017"},{"key":"pone.0293484.ref003","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/B978-1-4160-3406-3.50027-5","article-title":"Effects of Pressure","author":"A Shupak","year":"2008","journal-title":"Physiology and Medicine of Hyperbaric Oxygen Therapy"},{"issue":"5","key":"pone.0293484.ref004","first-page":"393","article-title":"Middle ear barotrauma in hyperbaric oxygen therapy","volume":"41","author":"M 3rd Heyboer","year":"2014","journal-title":"Undersea Hyperb Med"},{"issue":"6","key":"pone.0293484.ref005","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1089\/wound.2016.0718","article-title":"Hyperbaric Oxygen Therapy: Side Effects Defined and Quantified","volume":"6","author":"M 3rd Heyboer","year":"2017","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"4","key":"pone.0293484.ref006","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1378\/chest.120.4.1407","article-title":"Pulmonary edema associated with hyperbaric oxygen therapy.","volume":"120","author":"LK Weaver","year":"2001","journal-title":"Chest"},{"key":"pone.0293484.ref007","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/1-4020-4448-8_6","volume-title":"Handbook on Hyperbaric Medicine","author":"D Mathieu","year":"2006"},{"issue":"10","key":"pone.0293484.ref008","first-page":"1357","article-title":"Increased adrenal epinephrine and norepinephrine in spontaneously hypertensive rats treated with hyperbaric oxygen","volume":"30","author":"T Nakada","year":"1984","journal-title":"Hinyokika kiyo Acta urologica Japonica"},{"issue":"2","key":"pone.0293484.ref009","doi-asserted-by":"crossref","first-page":"93","DOI":"10.22462\/3.4.2017.2","article-title":"Effect of hyperbaric oxygen therapy on blood pressure in patients undergoing treatment","volume":"44","author":"M Heyboer Rd","year":"2017","journal-title":"Undersea Hyperb Med"},{"issue":"5","key":"pone.0293484.ref010","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/0002-9149(65)90350-4","article-title":"Cardiovascular and Blood Gas Responses to Hyperbaric Oxygenation","volume":"15","author":"RE Whalen","year":"1965","journal-title":"Am J Cardiol"},{"key":"pone.0293484.ref011","unstructured":"Pisarello JB CJ, Lambertsen CJ, Gelfand R, editor Human circulatory responses to prolonged hyperbaric hyperoxia in Predictive Studies V. Proceedings of the Ninth International Symposium on Underwater and Hyperbaric Physiology, Undersea and Hyperbaric Medical Society; 1987."},{"issue":"4","key":"pone.0293484.ref012","first-page":"229","article-title":"Hemodynamic modifications during hyperbaric oxygen therapy","volume":"7","author":"RM Pelaia P","year":"1992","journal-title":"J Hyperb Med"},{"issue":"7","key":"pone.0293484.ref013","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nm718","article-title":"Nitric oxide in the human respiratory cycle","volume":"8","author":"TJ McMahon","year":"2002","journal-title":"Nat Med"},{"issue":"1","key":"pone.0293484.ref014","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1152\/japplphysiol.91012.2008","article-title":"Arterial and pulmonary arterial hemodynamics and oxygen delivery\/extraction in normal humans exposed to hyperbaric air and oxygen","volume":"107","author":"LK Weaver","year":"2009","journal-title":"J Appl Physiol (1985)"},{"issue":"20","key":"pone.0293484.ref015","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17207586","article-title":"Magnitude and Clinical Predictors of Blood Pressure Changes in Patients Undergoing Hyperbaric Oxygen Therapy: A Retrospective Study","volume":"17","author":"S Schiavo","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"pone.0293484.ref016","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1042\/CS20030293","article-title":"Haemodynamic effects of hyperbaric hyperoxia in healthy volunteers: an echocardiographic and Doppler study","volume":"106","author":"F Molenat","year":"2004","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"pone.0293484.ref017","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cjca.2017.08.022","article-title":"2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure","volume":"33","author":"JA Ezekowitz","year":"2017","journal-title":"Can J Cardiol"},{"issue":"36","key":"pone.0293484.ref018","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"TA McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"3","key":"pone.0293484.ref019","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","article-title":"Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure","volume":"23","author":"B Bozkurt","year":"2021","journal-title":"European Journal of Heart Failure"},{"issue":"18","key":"pone.0293484.ref020","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"PA Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"9","key":"pone.0293484.ref021","first-page":"582","article-title":"Heart Failure with Preserved Ejection Fraction: Diagnosis and Management","volume":"96","author":"JD Gazewood","year":"2017","journal-title":"Am Fam Physician"},{"issue":"6","key":"pone.0293484.ref022","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/eurheartj\/ehq426","article-title":"Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment","volume":"32","author":"BA Borlaug","year":"2011","journal-title":"Eur Heart J"},{"issue":"11","key":"pone.0293484.ref023","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJMcp022709","article-title":"Clinical practice. Diastolic heart failure","volume":"351","author":"GP Aurigemma","year":"2004","journal-title":"N Engl J Med"},{"issue":"2","key":"pone.0293484.ref024","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1152\/jappl.1972.32.2.223","article-title":"Hemodynamic effects of oxygen at 1 and 2 Ata pressure in healthy subjects","volume":"32","author":"AC Kenmure","year":"1972","journal-title":"J Appl Physiol"},{"issue":"5","key":"pone.0293484.ref025","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s10554-020-01773-0","article-title":"The effect of hyperbaric oxygenation therapy on myocardial function","volume":"36","author":"M Leitman","year":"2020","journal-title":"Int J Cardiovasc Imaging"},{"issue":"2","key":"pone.0293484.ref026","first-page":"158","article-title":"The Effect of Hyperbaric Oxygen Therapy on Myocardial Perfusion after the Implantation of Drug-Eluting Stents","volume":"48","author":"Y Li","year":"2018","journal-title":"Ann Clin Lab Sci"},{"issue":"3","key":"pone.0293484.ref027","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1620\/tjem.214.281","article-title":"Hyperbaric oxygen therapy improves myocardial diastolic function in diabetic patients","volume":"214","author":"M Aparci","year":"2008","journal-title":"Tohoku J Exp Med"},{"issue":"2","key":"pone.0293484.ref028","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1378\/chest.120.2.467","article-title":"Effect of hyperoxia on left ventricular function and filling pressures in patients with and without congestive heart failure","volume":"120","author":"S Mak","year":"2001","journal-title":"Chest"},{"issue":"3","key":"pone.0293484.ref029","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/ejhf.1741","article-title":"How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"22","author":"B Pieske","year":"2020","journal-title":"Eur J Heart Fail"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0293484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T18:49:50Z","timestamp":1707418190000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0293484"}},"subtitle":[],"editor":[{"given":"Yashendra","family":"Sethi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,2,8]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0293484","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,8]]}}}